UBS Group’s Medical Properties Trust MPT Stock Holding History

UBS Group’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,900	Closed	-$9.33K	–	9772
2023 Q4	$9.33K	Buy	+1,900	New	+$9.3K	﹤0.01%	7497
2023 Q3	–	Sell	-70,000	Closed	-$648K	–	9785
2023 Q2	$648K	Buy	70,000 +30,300	+76%	+$256K	﹤0.01%	4602
2023 Q1	$326K	Sell	39,700 -143,700	-78%	-$1.59M	﹤0.01%	5016
2022 Q4	$2.04M	Buy	183,400 +35,000	+24%	+$407K	﹤0.01%	3372
2022 Q3	$1.76M	Buy	+148,400	New	+$2.25M	﹤0.01%	3274
2017 Q4	–	Sell	-8,900	Closed	-$117K	–	7998
2017 Q3	$117K	Sell	8,900 -24,400	-73%	-$314K	﹤0.01%	5221
2017 Q2	$429K	Buy	+33,300	New	+$443K	﹤0.01%	4220

Other funds holding MPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

UBS Group's MPT Position: Q2 2026 in Review

UBS Group increased its Medical Properties Trust (MPT) stake by 16% in Q2 2026, buying an estimated $2.11M and bringing the position to 3,142,032 shares worth $14.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3024.

UBS Group first reported a position in MPT in Q4 2014 and has held it in 47 quarters since. The position peaked at $43.4M in Q3 2022. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

UBS Group held 3,142,032 shares of Medical Properties Trust worth $14.5M as of Q2 2026.
UBS Group bought 426,501 Medical Properties Trust shares in Q2 2026, an estimated $2.11M.
Medical Properties Trust made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3024 holding.
UBS Group first reported a position in Medical Properties Trust in Q4 2014 and has held it in 47 quarters since.
UBS Group's Medical Properties Trust position peaked at $43.4M in Q3 2022.
489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.